Brainsonix is developing ultrasound-based neuromodulation technologies designed to influence brain activity without surgery or implants.
Related Posts
Press
BrainSonix Congratulates Dr. Susan Bookheimer on Her NIH R01 for Alzheimer’s Disease and Mild Cognitive Impairment Research!
January 20, 2026
BrainSonix Congratulates Dr. Susan Bookheimer on Her NIH R01 for Alzheimer’s Disease and Mild Cognitive Impairment Research!
News
Preliminary Examination of the Effects of Focused Ultrasound on Living Skin and Temperature at the Skin–Transducer Interface
January 6, 2026
Preliminary Examination of the Effects of Focused Ultrasound on Living Skin and Temperature at the Skin–Transducer Interface
News
Safety of Focused Ultrasound Neuromodulation in Humans With Temporal Lobe Epilepsy
January 6, 2026